U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985355) titled 'A Study of MHB046C Injection in Patients With Advanced Solid Tumors' on May 07.
Brief Summary: This is a first-in-human, open-label, multicenter Phase I/II study of MHB046C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB046C monotherapy.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Cancer
Intervention:
DRUG: MHB046C
IV administration of MHB046C Q3W; Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and confirmed disease progressi...